These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 13867505)
1. [Observations on hormonal therapy of breast cancer in women]. PFEIFFER J Ther Ggw; 1959 Jan; (1):1-4. PubMed ID: 13647456 [No Abstract] [Full Text] [Related]
2. [ANABOLIC DRUGS AND FEMALE VOICE]. MULLER A Schweiz Med Wochenschr; 1963 Nov; 93():1599-600. PubMed ID: 14153114 [No Abstract] [Full Text] [Related]
3. [On side-effects of virilizing drugs with special reference to the voice]. BAUER H Munch Med Wochenschr; 1963 Mar; 105():682-5. PubMed ID: 13966924 [No Abstract] [Full Text] [Related]
4. [VOICE DAMAGES IN WOMEN DUE TO ADROGENIC AND ANABOLIC HORMONES]. ARNDT HJ Dtsch Med Wochenschr; 1963 Nov; 88():2336-9. PubMed ID: 14111923 [No Abstract] [Full Text] [Related]
7. [Changes in the female voice caused by virilizing and anabolic hormones]. BERENDES J Folia Phoniatr (Basel); 1962; 14():265-71. PubMed ID: 13867505 [No Abstract] [Full Text] [Related]
8. [POST-PUBERAL VIRILISM CAUSED BY ADRENAL CORTEX TUMOR. HORMONE METABOLISM AND STEROIDOGENESIS IN VITRO OF A VIRILIZING ADENOMA. REVIEW OF THE LITERATURE]. BOMPIANI A; MONETA E; ROVERSI GD Ann Ostet Ginecol; 1963 Dec; 85():975-1047. PubMed ID: 14118566 [No Abstract] [Full Text] [Related]
9. [Physician's responsibility in the use of anabolic steroids in relation to the voice]. Berendes J Folia Phoniatr (Basel); 1968; 20(6):379-86. PubMed ID: 4305577 [No Abstract] [Full Text] [Related]
10. [Avoidable and not avoidable damage in hormone therapy. Cortisone osteoporosis and virilizing effect of anabolic steroids]. Labhart A Schweiz Med Wochenschr; 1966 Jun; 96(25):807-13. PubMed ID: 4863375 [No Abstract] [Full Text] [Related]
11. Virilizing adrenal adenoma with studies on the steroid content of the adrenal venous effluent and a review of the literature. Gabrilove JL; Seman AT; Sabet R; Mitty HA; Nicolis GL Endocr Rev; 1981; 2(4):462-70. PubMed ID: 6796401 [No Abstract] [Full Text] [Related]
12. Risks of menopausal androgen supplementation. Slayden SM Semin Reprod Endocrinol; 1998; 16(2):145-52. PubMed ID: 9711680 [TBL] [Abstract][Full Text] [Related]